Regulations.gov document: Dermatologic and Ophthalmic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public
Docket; Request for Comments—New Drug Application (NDA) 219694 for Atropine Sulfate Ophthalmic Solution, 0.01% — retained record — High Signal
Regulations.gov document: Dermatologic and Ophthalmic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public
Docket; Request for Comments—New Drug Application (NDA) 219694 for Atropine Sulfate Ophthalmic Solution, 0.01%